If you are looking for the best fertility tests after 35, you are probably not looking for more numbers alone. You want to know what those numbers mean for your chances, what could be getting in the way, and what to do next without losing more valuable time.
Fertility does not switch off at 35. But age-related changes in egg number and egg quality become more relevant, while conditions such as endometriosis, fibroids, thyroid disorders and male-factor fertility may also come into sharper focus. A well-chosen assessment can replace guesswork with a clear, clinician-led plan.
Why fertility testing after 35 needs a joined-up view
No single blood test can tell you whether you will conceive naturally, how quickly it will happen, or whether IVF will work. Fertility is a picture made up of ovulation, ovarian reserve, the uterus and fallopian tubes, sperm health, medical history, timing and age.
That is why the most useful testing is not necessarily the longest list of tests. It is the right combination for your circumstances, interpreted in context. An AMH result, for example, can be informative about ovarian reserve, but it does not measure egg quality and should never be treated as a verdict on your ability to become pregnant.
If you are 36 or over and have been having regular, unprotected sex for six months without conceiving, it is sensible to seek a fertility assessment. Do not wait for that point if your periods are absent or very irregular, you have a history of ectopic pregnancy, pelvic surgery, endometriosis, chemotherapy, recurrent miscarriage, or known concerns about sperm health.
Best fertility tests after 35: start with the foundations
A good initial assessment often begins with hormone testing and a detailed review of your cycles, symptoms, health history, medication and lifestyle. If you are trying with a partner, both people should be assessed early. Fertility difficulties are not solely a women’s health issue, and testing one partner while leaving the other unexplored can create unnecessary delay.
Hormone blood tests
A targeted hormone panel can help establish whether ovulation is likely, how the ovaries may respond to fertility medication, and whether another hormonal issue needs attention.
AMH, or anti-Müllerian hormone, is commonly used as an indicator of ovarian reserve - the remaining pool of recruitable eggs. It is useful for planning, particularly where IVF or egg freezing may be under consideration. A lower AMH may suggest fewer eggs are likely to be collected during treatment, but pregnancies can and do happen at a wide range of AMH levels.
FSH, LH and oestradiol are often tested early in the menstrual cycle, usually on days two to five. Together, they provide further context around ovarian signalling. Their value is strongest when they are read alongside AMH, age and an ultrasound scan rather than in isolation.
Progesterone is usually checked in the second half of the cycle, around seven days before your expected period. It can help confirm that ovulation has occurred, although a single result may not explain every irregular cycle. Where cycles vary in length, timing the test correctly matters more than following a fixed calendar date.
Thyroid function and prolactin are also important. Thyroid disorders can affect ovulation and pregnancy, while raised prolactin can interfere with the hormonal signals needed for regular ovulation. Depending on symptoms, clinicians may also consider androgen testing for possible polycystic ovary syndrome, as well as tests for glucose regulation or vitamin deficiencies.
Pelvic ultrasound and antral follicle count
A transvaginal pelvic ultrasound provides information that blood tests cannot. It can assess the ovaries, look for cysts, and identify signs of fibroids, adenomyosis or other uterine features that may affect conception or pregnancy.
During the scan, a clinician may count small resting follicles in the ovaries. This is called an antral follicle count, or AFC. Like AMH, it is mainly a guide to ovarian reserve and likely response to stimulation, not a direct measure of egg quality.
For someone with painful periods, pelvic pain, pain during sex or very heavy bleeding, ultrasound may be especially helpful. It can identify some causes of symptoms, although a normal scan does not rule out endometriosis. More specialist investigation may be needed where the history strongly suggests it.
Semen analysis
A semen analysis is one of the most valuable early fertility tests and should not be an afterthought. It assesses sperm concentration, movement and shape, alongside semen volume. These factors can affect the likelihood of sperm reaching and fertilising an egg.
Sperm results can vary from sample to sample, particularly after illness with fever, significant stress, heat exposure or changes in alcohol intake. An abnormal result is therefore commonly repeated before firm conclusions are drawn. A clinician may also recommend hormone testing, examination for varicocele, infection screening or a referral to an andrology specialist.
Sperm DNA fragmentation testing can be useful in selected situations, such as recurrent miscarriage, repeated IVF failure or unexplained infertility. It is not automatically the best first test for everyone. The result is most valuable when it will change the next step in care.
Fallopian tube testing
Healthy ovaries and regular ovulation are only part of the pathway. At least one fallopian tube generally needs to be open for natural conception. A tubal patency test may be recommended if you have been trying for a while, have had a previous pelvic infection, ectopic pregnancy, abdominal surgery or endometriosis.
This is usually arranged through a fertility clinic or gynaecology service rather than as an at-home test. Depending on your history, it may involve an X-ray dye test or an ultrasound-based procedure. Your clinician can explain which approach is suitable and when it should be done.
Which tests matter most for your situation?
The right sequence depends on your fertility story. If your periods are predictable and you have only recently started trying, hormone testing, cycle review and semen analysis may provide a sensible starting point. If your periods are irregular, ovulation-focused hormone testing becomes more urgent.
If you are considering IVF or egg freezing, AMH and antral follicle count can help with planning and expectations around treatment response. They cannot tell you whether to delay pregnancy safely, because age remains the strongest predictor of egg quality.
For recurrent miscarriage, testing may extend beyond the standard fertility panel. Depending on your history, a specialist may consider thyroid markers, uterine assessment, genetic factors and antiphospholipid syndrome screening. This deserves sensitive, individual care rather than a generic test package.
If there is a known medical condition, a family history of early menopause, previous cancer treatment or use of testosterone or anabolic steroids, say so from the outset. These details may change the tests recommended and the pace of referral.
Make sure your results lead somewhere
At-home collection can make an initial hormone or sperm assessment more private and accessible, but the real value lies in what follows. A result without clinical context can create false reassurance or unnecessary alarm.
Before testing, note the first day of your last period, usual cycle length, current medication and supplements, previous pregnancies, miscarriages and relevant medical diagnoses. If you are testing progesterone, make sure the collection date is matched to your own cycle. If a semen sample is being analysed, follow the abstinence and collection instructions carefully, as these affect accuracy.
Once results are available, ask three practical questions: What does this result suggest? What does it not tell us? What is the next action, and how soon should we take it? A clear answer might be lifestyle support and repeat testing, treatment for a hormonal issue, targeted imaging, or an early fertility clinic referral.
ProFertility combines medical-grade home testing with clinician interpretation, so results can become a personalised plan rather than another uncertain data point.
A timely answer can be a form of care
Testing after 35 is not about putting your fertility under a microscope or assuming the worst. It is about giving yourself enough information to make decisions with care, confidence and appropriate urgency. Whether the next step is trying with better timing, addressing a treatable barrier or moving towards specialist treatment, you deserve a path that feels clear and supported.